Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: SESTD1 ENSXETG00000015051

.

Description

SEC14 and spectrin domain containing 1 [Source:Xenbase;Acc:XB-GENE-977656]

Location

Primary_assembly 9: 63,577,040-63,669,529 forward strand.

UCB_Xtro_10.0:CM004451.2

About this gene

This gene has 6 transcripts (splice variants), 217 orthologues and 19 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSXETT00000062079.3	SESTD1-201	3515	696aa	ENSXETP00000058869.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	Q5M7P4	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSXETT00000101692.2	SESTD1-205	3456	694aa	ENSXETP00000080653.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A6I8RIM0	-
ENSXETT00000032937.5	SESTD1-204	3429	685aa	ENSXETP00000032937.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	F7DGK3	-
ENSXETT00000078079.2	SESTD1-206	3426	684aa	ENSXETP00000068797.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A6I8QHE7	-
ENSXETT00000079439.2	SESTD1-202	3401	658aa	ENSXETP00000077813.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A6I8R9V0	-
ENSXETT00000103189.2	SESTD1-203	3392	655aa	ENSXETP00000072908.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A6I8QUQ3	-

.

Summary

.

.